New injection shows promise for opioid addiction treatment
NCT ID NCT06576843
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new injectable medication called INDV-6001 in 123 adults with moderate to severe opioid use disorder. The goal was to see how the drug moves through the body, if it is safe, and how well people tolerate it. Participants received multiple doses, and researchers also compared injections in the abdomen, thigh, and upper arm to find the best spot for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Artemis Institute for Clinical Research
San Diego, California, 92103, United States
-
Chicago Clinical Research Institute Inc.
Chicago, Illinois, 60607, United States
-
Hassman Research Institute (Cenexel HRI - Marlton)
Marlton, New Jersey, 08053, United States
-
Innovative Clinical Research, Inc.
Miami Lakes, Florida, 33016, United States
-
Insite Clinical Research, LLC
DeSoto, Texas, 75115, United States
-
Memorial Hermann Village
Houston, Texas, 77043, United States
-
Midwest Clinical Research
Dayton, Ohio, 45417, United States
-
Pillar Clinical Research
Richardson, Texas, 75080, United States
-
Precise Research Centers
Flowood, Mississippi, 39232, United States
-
Progressive Clinical Research
Bountiful, Utah, 84010, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.